FIELD: medicine, otorhinolaryngology.
SUBSTANCE: method involves administration in patient 1% emoxipine solution in the volume 1 ml to lateral and posterior sections of mouth-pharynx after its preliminary application anesthesia with 2% lidocaine solution by submucosa injection. The treatment course is 5-10 procedures with break for 1 day. Method provides the stable clinical effect of treatment based on rapid accumulation of the required concentration of the medicinal preparation both in pharynx mucosa and in blood. Invention can be used in treatment of chronic pharyngitis.
EFFECT: improved method of treatment.
2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CHRONIC PHARYNGITIS WITH NOVOCAINE AND MEXIDOL SOLUTION | 2009 |
|
RU2394567C1 |
TREATMENT METHOD FOR CHRONICAL ATROPHIC PHARYNGITIS | 2016 |
|
RU2613186C1 |
METHOD OF TREATING CHRONIC PHARYNGITIS | 2009 |
|
RU2394565C1 |
METHOD OF TREATING CHRONIC PHARYNGITIS WITH NOVOCAINE AND LAZOLVAN SOLUTION | 2009 |
|
RU2394566C1 |
METHOD OF CHRONIC ATROPHIC PHARYNGITIS MEDICAL TREATMENT | 2006 |
|
RU2326661C1 |
METHOD OF TREATING CHRONIC PHARYNGITIS | 2015 |
|
RU2602692C1 |
COMPREHENSIVE METHOD FOR TREATMENT OF ATROPHIC PHARYNGITIS | 2023 |
|
RU2803947C1 |
METHOD OF TREATING CHRONIC PHARYNGITIS | 2020 |
|
RU2736046C1 |
METHOD FOR TREATING THE CASES OF PHARYNGITIS | 2001 |
|
RU2198704C1 |
METHOD OF REHABILITATION OF WORKERS WITH CHRONIC OCCUPATIONAL DISEASES OF RESPIRATORY ORGANS: RHINOPHARYNGITIS, TRACHEOBRONCHITIS CAUSED BY EXPOSURE TO HARMFUL FACTORS OF TITANIUM-MAGNESIUM PRODUCTION | 2019 |
|
RU2716962C1 |
Authors
Dates
2006-08-20—Published
2005-03-22—Filed